BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 27713133)

  • 1. Long non-coding RNAs in anti-cancer drug resistance.
    Chen QN; Wei CC; Wang ZX; Sun M
    Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA mediated drug resistance in breast cancer.
    Singh D; Assaraf YG; Gacche RN
    Drug Resist Updat; 2022 Jul; 63():100851. PubMed ID: 35810716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer.
    Zhou H; Feng B; Abudoureyimu M; Lai Y; Lin X; Tian C; Huang G; Chu X; Wang R
    Life Sci; 2020 Nov; 261():118362. PubMed ID: 32871184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-Coding RNA and Chemoresistance in Bladder Cancer - A Mini Review.
    Lima APB; da Silva GN
    Cancer Invest; 2023 Feb; 41(2):164-172. PubMed ID: 36373675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
    Zhang X; Yang H
    Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.
    Pecero ML; Salvador-Bofill J; Molina-Pinelo S
    Cell Oncol (Dordr); 2019 Feb; 42(1):1-12. PubMed ID: 30361825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNAs (lncRNA) in the pathogenesis of gastric cancer cells: molecular mechanisms and involvement miRNAs.
    Saleh RO; Al-Hawary SIS; Hammoud A; Hjazi A; Ayad Abdulrazzaq S; Rajput P; Alawsi T; Alnajar MJ; Alawadi A
    Mol Biol Rep; 2024 May; 51(1):615. PubMed ID: 38704760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Long Non-Coding RNA KMU15 Promotes Growth and Chemoresistance of Bladder Cancer.
    Huang Y; Luan T; Bao X; Fu S; Li N; Li H; Wang H; Li C; Wang J
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives.
    Li Y; Lu L; Wu X; Li Q; Zhao Y; Du F; Chen Y; Shen J; Xiao Z; Wu Z; Hu W; Cho CH; Li M
    Int J Biol Sci; 2021; 17(11):2737-2755. PubMed ID: 34345204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.
    Ahmadpour ST; Orre C; Bertevello PS; Mirebeau-Prunier D; Dumas JF; Desquiret-Dumas V
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs regulate drug resistance in cancer.
    Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
    Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer.
    Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y
    J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistance.
    Liu W; Zuo B; Liu W; Huo Y; Zhang N; Yang M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188982. PubMed ID: 37734560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
    Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
    Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA as a multifunctional regulator in cancer multi-drug resistance.
    He J; Zhu S; Liang X; Zhang Q; Luo X; Liu C; Song L
    Mol Biol Rep; 2021 Aug; 48(8):1-15. PubMed ID: 34333735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.